Company / Working Capital
West Pharmaceutical Services Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.3B
FY2025
5-year range
$987.7M / $1.4B
FY2021-FY2025
Trend
+34.0%
vs FY2024
Sector context
#24 of 160
Health Care
What the data says
West Pharmaceutical Services's working capital of $1.3B is higher than 85% of companies in the Health Care sector (FY2025). Working Capital returned to growth in FY2025 after 2 years of decline, reaching $1.3B.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +8.7%. Top quartile in the Health Care sector.
Improved from $1.3B to $1.3B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- +8.7%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 160This company $1.3B Sector average $757.1M
▼
+74.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +8.7%, indicating consistent growth.
- In FY2025, working capital increased 34.0% year-over-year.
- Ranks #24 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +34.0% |
| FY2024 | $987.7M | -21.9% |
| FY2023 | $1.3B | -9.7% |
| FY2022 | $1.4B | +22.0% |
| FY2021 | $1.1B | +31.9% |
| FY2020 | $870.3M | +21.4% |
| FY2019 | $717.1M | +17.4% |
| FY2018 | $610.7M | +31.6% |
| FY2017 | $464.0M | +15.7% |
| FY2016 | $400.9M | +11.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026